Storage & Handling
Cold Chain Shipping of Lyophilised Peptides Across Canada
In short
Lyophilised peptides tolerate transit temperature excursions more readily than solutions because water removal reduces degradation pathways. Appropriate insulated packaging, coolant selection based on transit time and season, and thorough receiving inspection protect material integrity across Canada's varied geography.
Key points
- Lyophilised peptides are more thermally stable in transit than solution-phase preparations because removal of water substantially slows the dominant degradation pathways.
- Coolant choice - dry ice, wet ice, or phase-change materials - depends on the required temperature range, transit duration, and ambient conditions expected during the journey.
- Canada's geographic diversity means transit times to remote or northern destinations can be substantially longer than to major research centres, requiring larger coolant masses or alternative routing.
- Importing research peptides from outside Canada requires accurate customs documentation; incomplete declarations can delay shipments beyond coolant lifetime.
- Receiving inspection should be documented with condition notes, coolant status, and lot number before the material enters inventory.
Thermal stability of lyophilised peptides compared with solutions
Lyophilisation removes the bulk of the water from a peptide preparation by freezing the material and applying vacuum to sublimate ice directly to vapour. The resulting powder has a water content typically in the range of one to five percent by mass. At this moisture level, the dominant degradation pathways that affect solution-phase peptides - hydrolysis of peptide bonds, deamidation of asparagine and glutamine residues, oxidation in the presence of dissolved oxygen - are substantially slower because the reaction medium is largely absent.
This improved thermal stability means that lyophilised peptide material can tolerate brief episodes of ambient or modestly elevated temperature during transit without the rapid degradation that would occur in a dissolved preparation. This is not unlimited tolerance: sustained exposure to high temperatures or significant moisture ingress can initiate degradation even in the dry state, and the acceptable excursion varies with the specific compound, its stability profile, and the duration of exposure.
Understanding the difference in thermal tolerance between the two forms is the starting point for designing an appropriate shipping configuration. A lyophilised shipment does not require the same refrigeration that a peptide solution would, but that does not mean it requires no temperature management. The acceptable window for temperature variation is wider and the time-sensitivity of coolant maintenance is less acute, but an adequate insulated system is still appropriate practice.
Insulated packaging and coolant selection
Insulated shippers for temperature-sensitive materials typically consist of an inner insulated container made of expanded polystyrene or vacuum-insulated panels, a coolant, and an outer shipping carton. The thermal performance of the system depends on the insulation value, the initial temperature of the coolant at the time of packing, the ambient temperature profile expected during transit, and the total coolant mass relative to the payload.
Dry ice maintains compartment temperatures well below zero and is appropriate for materials that should remain frozen throughout transit. It sublimes continuously and must be packed in sufficient quantity to last the full transit duration with a reasonable safety margin. Dry ice shipments are subject to Transport Canada and IATA regulations regarding quantity limits and labelling for air transport, which adds a regulatory step to international and inter-provincial air freight.
Wet ice and phase-change materials maintain temperatures in the two-to-eight degree Celsius range, appropriate for materials that should not freeze but should remain refrigerated. For lyophilised peptides stored at minus twenty Celsius where brief excursion to refrigerated temperatures does not cause harm, either coolant class may be appropriate depending on the supplier's shipping specification. Phase-change materials do not drain as ice melts and are often preferred for multi-day shipments.
Canadian geography and transit time realities
Canada's landmass encompasses a wide range of climatic and logistical conditions that affect temperature-sensitive shipping. Deliveries to major research centres in Vancouver, Toronto, Montreal, or Calgary are typically served by direct air or ground freight with transit times of one to two days. Deliveries to smaller centres, remote communities, or northern research stations may require multiple carrier handoffs, overnight or multi-day ground segments, or charter freight, extending total transit time considerably.
Seasonal temperature extremes affect the effectiveness of insulated packaging. Prairie and northern shipments in winter can encounter ambient temperatures below minus thirty Celsius, at which point maintaining the payload above freezing requires active thermal management. Summer shipments to southern destinations face the opposite challenge: ambient temperatures in distribution facilities or vehicles can overwhelm lightly insulated packaging designed for moderate conditions.
Confirming estimated transit time with the carrier before configuring packaging is recommended practice. Using the worst-case ambient temperature for the shipping season and route when sizing coolant mass, and considering direct air freight over ground transport for deliveries to remote destinations, reduces the risk of coolant exhaustion before arrival. Carrier schedule estimates for remote northern addresses are particularly variable and should be confirmed rather than assumed.
Regulatory and customs considerations for Canadian shipments
Research peptides shipped within Canada do not in general require Health Canada import permits when moving between provinces, but the regulatory status of individual compounds should be confirmed with the institutional compliance office before ordering. Some compounds may have specific scheduling or import considerations under the Controlled Drugs and Substances Act or related federal regulations, and assumptions based on other compounds in the same chemical class are not a reliable substitute for specific confirmation.
For materials imported from outside Canada, accurate customs documentation is essential. The commercial invoice must describe the goods accurately, including the chemical or common name, intended use as laboratory research material, quantity, and declared value. Incomplete or inaccurate declarations are a leading cause of customs holds that can extend transit times by days, potentially beyond the useful lifetime of the coolant.
Some institutions require that all external research material imports be coordinated through the office of research or a designated materials management function. This ensures that import declarations are consistent with institutional representations, that materials arrive through a documented chain of custody, and that any required institutional permissions are in place before the shipment departs. Checking institutional requirements before placing an international order avoids delays at arrival.
Receiving inspection and arrival documentation
A proper receiving inspection for a temperature-sensitive shipment begins before the outer packaging is opened. The external condition of the carton - any signs of crushing, moisture damage, or rough handling - should be noted. If a temperature indicator card or electronic data logger is accessible through the carton, its status should be checked and recorded before proceeding.
Once the inner insulated container is opened, the state of the coolant and the condition of the inner packaging should be assessed. Dry ice should have remaining mass consistent with the transit time; wet ice should not have fully drained. Vials should be intact, undamaged, and still cold to the touch or at the expected temperature. If any of these conditions are not met, the material should be quarantined pending communication with the supplier.
Receiving documentation should record the date and time of receipt, the carrier and tracking reference, the lot number and description from the packing slip, the observed condition of the coolant and packaging, any temperature indicator status, and the name of the person conducting the inspection. This documentation becomes part of the material receipt record and supports chain-of-custody requirements as well as any subsequent investigation if the material performs unexpectedly in use.
Frequently asked questions
- Why are lyophilised peptides more stable during shipping than solutions?
- Lyophilisation removes the bulk of the water from the preparation, which substantially slows the hydrolysis and other water-mediated degradation pathways that affect solution-phase peptides. The dry powder tolerates broader temperature variation during transit, though extreme or sustained heat or moisture ingress can still initiate degradation.
- Should lyophilised peptides be shipped with dry ice or wet ice?
- The choice depends on the compound's storage specification and the transit conditions. Dry ice maintains frozen temperatures and is appropriate when sub-zero conditions are required throughout. Wet ice or phase-change materials maintain refrigerated temperatures and are used when freezing would not cause harm but elevated temperatures should be avoided. The supplier's recommended shipping conditions should be followed.
- How should I ship peptides to a remote northern Canadian location?
- Remote and northern destinations typically involve extended transit times with multiple carrier handoffs. Direct air freight reduces time in transit where available. Coolant mass should be sized for a worst-case transit duration that accounts for delays, and seasonal ambient temperatures should be factored into packaging selection. Confirming estimated transit time with the carrier before packing is advisable.
- Do I need a Health Canada import permit to receive research peptides from outside Canada?
- Most synthetic research peptides are not scheduled under the Controlled Drugs and Substances Act and do not require Health Canada import permits, but individual compound status should be confirmed with the institutional compliance office. Accurate commercial invoice documentation is required for all imported research materials regardless of scheduling status.
- What should I document when receiving a temperature-sensitive peptide shipment?
- Receipt documentation should include the date and time of receipt, carrier and tracking reference, lot number and description, coolant condition at arrival, temperature indicator status if present, packaging condition, and the name of the receiving staff member. This record supports chain-of-custody and any subsequent investigation of material performance.
- What should I do if the coolant is fully exhausted on arrival?
- The material should be quarantined and not placed into general inventory. The shipment condition should be documented with notes and photographs, and the supplier should be contacted promptly. The supplier can advise whether the transit temperature profile is consistent with maintained material integrity or whether the lot should be replaced.
Related compound monographs
Sourced literature reviews with citations, for the compounds this guide touches on.
More in Storage & Handling
- Shelf Life and Stability of Lyophilised Research Peptides: Room Temperature to Long-Term Storage5 min read
- Receiving and Storing Research Peptides in a Laboratory Setting7 min read
- Peptide Degradation: Oxidation, Deamidation, and Aggregation Pathways8 min read
Important research notice
This guide is reference material for qualified laboratories. It is not medical advice, and nothing on it describes or endorses use in humans or animals. Noreo Labs does not authorize any use outside a qualified laboratory.
